We are live on
!
Find out more
Royce & Associates Portfolio holdings
AUM
$12.4B
Turnover
20.64%
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.6B
AUM Growth
-$258M
(-0.76%)
Cap. Flow
-$892M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
1,511
New
98
Increased
472
Reduced
496
Closed
89
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Skin
NUS
|
+$123M |
| 2 |
Dana Inc
DAN
|
+$61.6M |
| 3 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$55.3M |
| 4 |
Civeo
CVEO
|
+$37.3M |
| 5 |
ePlus
PLUS
|
+$30M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$107M |
| 2 |
Helmerich & Payne
HP
|
+$90.6M |
| 3 |
Oil States International
OIS
|
+$59.7M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$59.4M |
| 5 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 24.45% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.92% |
| 5 | Materials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
EBIX
1076
DELISTED
Ebix Inc
EBIX
| $1.63M | ﹤0.01% |
113,745
+6,100
| +6% | +$94.8K |
2013 Q2
4 quarters
|
|
1077
DELISTED
Chart Industries
GTLS
| $1.61M | ﹤0.01% |
19,500
| – | – |
2013 Q2
4 quarters
|
|
|
GSV
1078
DELISTED
Gold Standard Ventures Corp.
GSV
| $1.58M | ﹤0.01% |
2,000,000
| – | – |
2013 Q2
4 quarters
|
|
1079
Everest Group
EG
$14.6B
| $1.57M | ﹤0.01% |
9,800
+3,200
| +48% | +$506K |
2013 Q2
4 quarters
|
|
1080
Oceaneering
OII
$4.28B
| $1.57M | ﹤0.01% |
20,121
+10,920
| +119% | +$801K |
2013 Q2
4 quarters
|
|
|
INFI
1081
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.57M | ﹤0.01% |
+123,400
| New | +$1.29M |
2014 Q2
0 quarters
|
|
1082
Abercrombie & Fitch
ANF
$6.45B
| $1.56M | ﹤0.01% |
36,100
-14,900
| -29% | -$575K |
2013 Q2
4 quarters
|
|
1083
Ceragon Networks
CRNT
$184M
| $1.56M | ﹤0.01% |
613,771
-365,929
| -37% | -$935K |
2013 Q4
2 quarters
|
|
|
ATHX
1084
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.55M | ﹤0.01% |
34,600
-2,560
| -7% | -$126K |
2014 Q1
1 quarter
|
|
1085
Baytex Energy
BTE
$3.61B
| $1.54M | ﹤0.01% |
33,400
-2,700
| -7% | -$115K |
2013 Q2
4 quarters
|
|
|
RTN
1086
DELISTED
Raytheon Company
RTN
| $1.52M | ﹤0.01% |
16,500
-9,500
| -37% | -$921K |
2013 Q2
4 quarters
|
|
1087
Titan Machinery
TITN
$535M
| $1.52M | ﹤0.01% |
+92,260
| New | +$1.55M |
2014 Q2
0 quarters
|
|
1088
RenaissanceRe
RNR
$14.3B
| $1.5M | ﹤0.01% |
14,009
+4,200
| +43% | +$430K |
2013 Q2
4 quarters
|
|
1089
Flowserve
FLS
$9B
| $1.49M | ﹤0.01% |
20,100
| – | – |
2013 Q2
4 quarters
|
|
|
HALL
1090
DELISTED
Hallmark Financial Services, Inc.
HALL
| $1.48M | ﹤0.01% |
13,800
| – | – |
2013 Q2
4 quarters
|
|
|
SIMG
1091
DELISTED
SILICON IMAGE INC
SIMG
| $1.48M | ﹤0.01% |
294,500
-8,000
| -3% | -$45.1K |
2013 Q2
4 quarters
|
|
1092
Trex
TREX
$4.71B
| $1.48M | ﹤0.01% |
205,600
| – | – |
2013 Q2
4 quarters
|
|
1093
Essex Property Trust
ESS
$17.3B
| $1.48M | ﹤0.01% |
8,000
| – | – |
2013 Q2
4 quarters
|
|
|
ZGNX
1094
DELISTED
Zogenix, Inc.
ZGNX
| $1.48M | ﹤0.01% |
91,810
| – | – |
2013 Q2
4 quarters
|
|
1095
Sensata Technologies
ST
$6.01B
| $1.45M | ﹤0.01% |
31,050
| – | – |
2014 Q1
1 quarter
|
|
1096
Cass Information Systems
CASS
$695M
| $1.44M | ﹤0.01% |
38,478
| – | – |
2013 Q2
4 quarters
|
|
1097
SIFCO Industries
SIF
$133M
| $1.43M | ﹤0.01% |
45,800
| – | – |
2013 Q2
4 quarters
|
|
1098
Brown & Brown
BRO
$22.7B
| $1.43M | ﹤0.01% |
93,000
-1,308,200
| -93% | -$19.7M |
2013 Q2
4 quarters
|
|
|
MWIV
1099
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $1.42M | ﹤0.01% |
10,000
| – | – |
2013 Q2
4 quarters
|
|
|
INDT
1100
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $1.41M | ﹤0.01% |
47,746
| – | – |
2013 Q2
4 quarters
|
|
Similar funds
Royce & Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Royce & Associates held 1,511 positions worth $33.6B, down 0.76% from $33.9B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Royce & Associates's Q2 2014 filing shows 98 new, 472 increased, 496 reduced and 89 closed positions. Its largest new stake was Civeo: 124,691 shares worth $37.5M. The largest sale was Zebra Technologies, an estimated $107M.
By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.
- Royce & Associates's largest Q2 2014 buy was Civeo: 124,691 shares worth $37.5M.
- Royce & Associates added most to Nu Skin in Q2 2014, an estimated $123M increase.
- Royce & Associates's biggest Q2 2014 reduction was Zebra Technologies, cutting an estimated $107M.
- Royce & Associates fully exited Entegris in Q2 2014, selling an estimated $35.5M.
- Royce & Associates's ten largest holdings make up 9.6% of its $33.6B portfolio in Q2 2014.
- Royce & Associates opened 98 new positions and closed 89 in Q2 2014.
- Royce & Associates's portfolio value fell 0.76% quarter-over-quarter to $33.6B.
Based on Royce & Associates's 13F filing for Q2 2014, filed 11 Aug 2014.